Investors in MedAdvisor Limited (ASX:MDR) had a good week, as its shares rose 7.0% to close at AU$0.23 following the release of its yearly results. The results overall were pretty much dead in line ...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Robert Read has been the CEO of MedAdvisor Limited (ASX:MDR) since 2015.
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But the main game is to find enough winners to more than offset the ...
We feel now is a pretty good time to analyse MedAdvisor Limited's (ASX:MDR) business as it appears the company may be on the cusp of a considerable accomplishment. MedAdvisor Limited, together with ...
MELBOURNE, Australia, Nov. 6, 2024 /PRNewswire/ -- MedAdvisor Solutions, a global leader in pharmacy-driven patient engagement solutions, announced today that new Telehealth functionality is now ...
MedAdvisor Limited (AU:MDR) has released an update. MedAdvisor Limited, a leader in personalized medication management, has issued a statement cautioning that their presentation is not an investment ...
MedAdvisor Solutions, a company specializing in pharmacy-driven patient engagement solutions, and Brand Engagement Network, a provider of safe, personalized customer engagement AI, shared that the ...
SINGAPORE - Australian medication platform MedAdvisor and healthcare service provider Zuellig Pharma have formed a 50:50 Singapore-based joint venture (JV) ZP MedAdvisor (ZPM) to commercialise ...
DALLAS, TX, UNITED STATES, March 31, 2026 /EINPresswire.com/ — MedAdvisor, a leader in patient engagement, claims analysis, and access-to-care solutions, and ...
MELBOURNE, Australia--(BUSINESS WIRE)--MedAdvisor (ASX:MDR), Australia’s leading digital medication management company, announces a $9.5 million strategic investment by one of Australasia’s leading ...
IRVING, Texas, Oct. 06, 2019 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (Nasdaq: HMSY), a leading U.S.-based provider of healthcare technology, analytics and engagement solutions, today announced that HMS ...
Australian Securities Exchange-listed medication management software company MedAdvisor has announced raising AU$9.5 million in a deal with healthcare company EBOS Group. Approximately 165 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results